AbCellera Biologics Inc.ABCLNASDAQ
Loading
Cash Flow PerformanceCompressed
Percentile Rank14
Studio
Year-over-Year Change

Free cash flow yield

Percentile
P14
Within normal range
vs 5Y Ago
-229.1x
Contraction
Streak
1 yr
Consecutive growthCompressed
PeriodValueYoY Change
2025-17.04%+21.4%
2024-21.68%-194.9%
2023-7.35%-203.7%
20227.09%+50.2%
20214.72%+6245.2%
20200.07%+824.4%
2019-0.01%+47.5%
2018-0.02%-